The Skin Microbiome of Patients With Atopic Dermatitis Normalizes Gradually During Treatment

Background: Atopic dermatitis (AD) is characterized by an altered skin microbiome dominantly colonized by S. aureus. Standard treatment includes emollients, anti-inflammatory medications and antiseptics. Objectives: To characterize changes in the skin microbiome during treatment for AD. Method...

Full description

Bibliographic Details
Main Authors: Khadka, Veda D, Key, Felix M, Romo-González, Carolina, Martínez-Gayosso, Adrián, Campos-Cabrera, Blanca L, Gerónimo-Gallegos, Armando, Lynn, Tucker C, Durán-McKinster, Carola, Coria-Jiménez, Rafael, Lieberman, Tami D, García-Romero, Maria T
Other Authors: Massachusetts Institute of Technology. Department of Civil and Environmental Engineering
Format: Article
Language:English
Published: Frontiers Media SA 2023
Online Access:https://hdl.handle.net/1721.1/148604
_version_ 1811088673606729728
author Khadka, Veda D
Key, Felix M
Romo-González, Carolina
Martínez-Gayosso, Adrián
Campos-Cabrera, Blanca L
Gerónimo-Gallegos, Armando
Lynn, Tucker C
Durán-McKinster, Carola
Coria-Jiménez, Rafael
Lieberman, Tami D
García-Romero, Maria T
author2 Massachusetts Institute of Technology. Department of Civil and Environmental Engineering
author_facet Massachusetts Institute of Technology. Department of Civil and Environmental Engineering
Khadka, Veda D
Key, Felix M
Romo-González, Carolina
Martínez-Gayosso, Adrián
Campos-Cabrera, Blanca L
Gerónimo-Gallegos, Armando
Lynn, Tucker C
Durán-McKinster, Carola
Coria-Jiménez, Rafael
Lieberman, Tami D
García-Romero, Maria T
author_sort Khadka, Veda D
collection MIT
description Background: Atopic dermatitis (AD) is characterized by an altered skin microbiome dominantly colonized by S. aureus. Standard treatment includes emollients, anti-inflammatory medications and antiseptics. Objectives: To characterize changes in the skin microbiome during treatment for AD. Methods: The skin microbiomes of children with moderate-to-severe AD and healthy children were investigated in a longitudinal prospective study. Patients with AD were randomized to receive either standard treatment with emollients and topical corticosteroids or standard treatment with the addition of dilute bleach baths (DBB) and sampled at four visits over a three-month period. At each visit, severity of AD was measured, swabs were taken from four body sites and the composition of the microbiome at those sites was assessed using 16S rRNA amplification. Results: We included 14 healthy controls and 28 patients. We found high relative abundances of S. aureus in patients, which correlated with AD severity and reduced apparent alpha diversity. As disease severity improved with treatment, the abundance of S. aureus decreased, gradually becoming more similar to the microbiomes of healthy controls. After treatment, patients who received DBB had a significantly lower abundance of S. aureus than those who received only standard treatment. Conclusions: There are clear differences in the skin microbiome of healthy controls and AD patients that diminish with treatment. After three months, the addition of DBB to standard treatment had significantly decreased the S. aureus burden, supporting its use as a therapeutic option. Further study in double-blinded trials is needed.
first_indexed 2024-09-23T14:05:44Z
format Article
id mit-1721.1/148604
institution Massachusetts Institute of Technology
language English
last_indexed 2024-09-23T14:05:44Z
publishDate 2023
publisher Frontiers Media SA
record_format dspace
spelling mit-1721.1/1486042023-03-18T03:18:59Z The Skin Microbiome of Patients With Atopic Dermatitis Normalizes Gradually During Treatment Khadka, Veda D Key, Felix M Romo-González, Carolina Martínez-Gayosso, Adrián Campos-Cabrera, Blanca L Gerónimo-Gallegos, Armando Lynn, Tucker C Durán-McKinster, Carola Coria-Jiménez, Rafael Lieberman, Tami D García-Romero, Maria T Massachusetts Institute of Technology. Department of Civil and Environmental Engineering Background: Atopic dermatitis (AD) is characterized by an altered skin microbiome dominantly colonized by S. aureus. Standard treatment includes emollients, anti-inflammatory medications and antiseptics. Objectives: To characterize changes in the skin microbiome during treatment for AD. Methods: The skin microbiomes of children with moderate-to-severe AD and healthy children were investigated in a longitudinal prospective study. Patients with AD were randomized to receive either standard treatment with emollients and topical corticosteroids or standard treatment with the addition of dilute bleach baths (DBB) and sampled at four visits over a three-month period. At each visit, severity of AD was measured, swabs were taken from four body sites and the composition of the microbiome at those sites was assessed using 16S rRNA amplification. Results: We included 14 healthy controls and 28 patients. We found high relative abundances of S. aureus in patients, which correlated with AD severity and reduced apparent alpha diversity. As disease severity improved with treatment, the abundance of S. aureus decreased, gradually becoming more similar to the microbiomes of healthy controls. After treatment, patients who received DBB had a significantly lower abundance of S. aureus than those who received only standard treatment. Conclusions: There are clear differences in the skin microbiome of healthy controls and AD patients that diminish with treatment. After three months, the addition of DBB to standard treatment had significantly decreased the S. aureus burden, supporting its use as a therapeutic option. Further study in double-blinded trials is needed. 2023-03-17T17:01:49Z 2023-03-17T17:01:49Z 2021 2023-03-17T16:57:47Z Article http://purl.org/eprint/type/JournalArticle https://hdl.handle.net/1721.1/148604 Khadka, Veda D, Key, Felix M, Romo-González, Carolina, Martínez-Gayosso, Adrián, Campos-Cabrera, Blanca L et al. 2021. "The Skin Microbiome of Patients With Atopic Dermatitis Normalizes Gradually During Treatment." Frontiers in Cellular and Infection Microbiology, 11. en 10.3389/FCIMB.2021.720674 Frontiers in Cellular and Infection Microbiology Creative Commons Attribution 4.0 International license https://creativecommons.org/licenses/by/4.0/ application/pdf Frontiers Media SA Frontiers
spellingShingle Khadka, Veda D
Key, Felix M
Romo-González, Carolina
Martínez-Gayosso, Adrián
Campos-Cabrera, Blanca L
Gerónimo-Gallegos, Armando
Lynn, Tucker C
Durán-McKinster, Carola
Coria-Jiménez, Rafael
Lieberman, Tami D
García-Romero, Maria T
The Skin Microbiome of Patients With Atopic Dermatitis Normalizes Gradually During Treatment
title The Skin Microbiome of Patients With Atopic Dermatitis Normalizes Gradually During Treatment
title_full The Skin Microbiome of Patients With Atopic Dermatitis Normalizes Gradually During Treatment
title_fullStr The Skin Microbiome of Patients With Atopic Dermatitis Normalizes Gradually During Treatment
title_full_unstemmed The Skin Microbiome of Patients With Atopic Dermatitis Normalizes Gradually During Treatment
title_short The Skin Microbiome of Patients With Atopic Dermatitis Normalizes Gradually During Treatment
title_sort skin microbiome of patients with atopic dermatitis normalizes gradually during treatment
url https://hdl.handle.net/1721.1/148604
work_keys_str_mv AT khadkavedad theskinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT keyfelixm theskinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT romogonzalezcarolina theskinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT martinezgayossoadrian theskinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT camposcabrerablancal theskinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT geronimogallegosarmando theskinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT lynntuckerc theskinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT duranmckinstercarola theskinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT coriajimenezrafael theskinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT liebermantamid theskinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT garciaromeromariat theskinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT khadkavedad skinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT keyfelixm skinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT romogonzalezcarolina skinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT martinezgayossoadrian skinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT camposcabrerablancal skinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT geronimogallegosarmando skinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT lynntuckerc skinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT duranmckinstercarola skinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT coriajimenezrafael skinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT liebermantamid skinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment
AT garciaromeromariat skinmicrobiomeofpatientswithatopicdermatitisnormalizesgraduallyduringtreatment